About the Company
We do not have any company description for VivoSim Labs, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on VivoSim Labs, INC.
VivoSim Labs Appoints New Chief Commercial Officer
VivoSim Labs ( (VIVS) ) has issued an announcement. On August 7, 2025, VivoSim Labs appointed Tony Lialin as Chief Commercial Officer, effective August 11, 2025. Lialin, with over two decades of ...
VivoSim: Fiscal Q1 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — VivoSim Labs, Inc. (VIVS) on Tuesday reported a loss of $2.8 million in its fiscal first quarter. On a per-share basis, the San Diego-based company said it had a loss ...
VivoSim Labs Inc
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary ...
VIVS Stock Quote Price and Forecast | CNN
View VivoSim Labs Inc VIVS stock quote prices, financial information, real-time forecasts, and company news from CNN.
VivoSim to Carry Forward Organovo 3D Bioprinting - Nasdaq
--Organovo Holdings, Inc. announced that it will carry forward its 3 D bioprinting and legacy technology as VivoSim Labs, Inc.. A name change of the Company to VivoSim Labs, Inc. will be effective ...
4OR - VivoSim Labs Inc Executives | Morningstar
Learn about the executive team and board of directors at VivoSim Labs Inc (4OR:XMUN) and review their bios and compensation over the latest fiscal years.
VIVS - VivoSim Labs Inc Key Metrics | Morningstar
Review the current VivoSim Labs Inc (VIVS:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if VIVS is the best investment for you.
VIVS | VivoSim Labs Inc. Annual Income Statement | MarketWatch
VivoSim Labs Inc. Annual stock financials by MarketWatch. View the latest VIVS financial statements, income statements and financial ratios.
VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To ...
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.
VivoSim Labs, Inc. (VIVS) Income Statement - Yahoo Finance
Get the detailed quarterly/annual income statement for VivoSim Labs, Inc. (VIVS). Find out the revenue, expenses and profit or loss over the last fiscal year.
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
Veteran commercial leader to scale AI-enabled NAMkind™ liver and intestine toxicology services in a rapidly growing marketSAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) ...
VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing ...
Similar Companies
Loading the latest forecasts...